Artelo Biosciences Inc.
13F holders, Q3 2024 (September 30)5holders −1
0new positions
1sold out
$1.14avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Artelo Biosciences Inc. in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($20K), Tower Research Capital LLC (TRC) ($6K) and Bank of America Corp. ($29).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G508
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $64 |
All 13F filers, Q2 2024 → Q3 2024: 3,144 shares sold, net −3,144 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Geode Capital Management, LLC | 0.00% | Reduce -12.4% | 17,350 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.0% | 5,183 | $6K |
| Bank of America Corp. | 0.00% | No change | 26 | $29 |
| Morgan Stanley | 0.00% | No change | 20 | $22 |
| Rothschild Investment LLC | 0.00% | No change | 8 | $9 |
"% of holder's portfolio" is ARTELO BIOSCIENCES INC's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.